Abstract
No public abstract is available from the verified source records.
Saleha Anwar, Sumaiya Khan, Sahar Afzal Khan, Suhel Parvez, Anas Shamsi
Abstract
Authors
Institutions
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Role of the active-site solvent in the thermodynamics of factor Xa ligand binding
10.1021/ja0771033 · 2008
Conformational dynamics of intrinsically disordered proteins regulate biomolecular condensate chemistry
10.1021/acs.chemrev.1c00774 · 2022
Unresolved referenced work
Kept as external metadata until matched
Linking machine learning and biophysical structural features in drug discovery
10.3389/fmolb.2024.1305272 · 2025
Probing the interaction of memantine, an important Alzheimer's drug, with human serum albumin: in silico and in vitro approach
10.1016/j.molliq.2021.116888 · 2021
Protein aggregation and neurodegenerative disease: structural outlook for the novel therapeutics
10.1002/prot.26561 · 2025
3D structure of the influenza virus polymerase complex: localization of subunit domains
10.1073/pnas.0307127101 · 2004
Systematic multiscale simulation of membrane protein systems
10.1016/j.sbi.2009.03.001 · 2009
Multiscale modeling of biomolecular systems: in serial and in parallel
10.1016/j.sbi.2007.03.004 · 2007
Provenance
crossref
Confidence 100%
ror
Confidence 99%
openalex
Confidence 95%
datacite
Confidence 0%
Advancing time-resolved structural biology: latest strategies in cryo-EM and X-ray crystallography
10.1038/s41592-025-02659-6 · 2025
Allosterism vs. orthosterism: recent findings and future perspectives on A2B AR physio-pathological implications
10.3389/fphar.2021.652121 · 2021
Fragment-to-hit-to-lead discovery of a novel pyridylurea scaffold of ATP competitive dual targeting type II topoisomerase inhibiting antibacterial agents
10.1021/jm401208b · 2013
Biophysical elucidation of fibrillation inhibition by sugar osmolytes in α-lactalbumin: multispectroscopic and molecular docking approaches
10.1021/acsomega.0c04062 · 2020
Natural products against tau hyperphosphorylation-induced aggregates: potential therapies for Alzheimer's disease
10.1002/ardp.202400721 · 2025
G-quadruplex–stalled eukaryotic replisome structure reveals helical inchworm DNA translocation
10.1126/science.adt1978 · 2025
The reflection of X-rays by crystals
10.1098/rspa.1913.0040 · 1913
The structure of some crystals as indicated by their diffraction of X-rays
10.1098/rspa.1913.0083 · 1913
Advances and challenges in time-resolved macromolecular crystallography
10.1126/science.aba0954 · 2021
A possible three-dimensional structure of bovine α-lactalbumin based on that of hen's egg-white lysozyme
10.1016/0022-2836(69)90487-2 · 1969
High-throughput screening assay datasets from the pubchem database
2017
High-resolution mapping of linear antibody epitopes using ultrahigh-density peptide microarrays
10.1074/mcp.m112.020800 · 2012
10.1007/978-1-60761-244-5_3
10.1007/978-1-60761-244-5_3
Plant-derived natural products: a source for drug discovery and development
10.3390/ddc3010011 · 2024
Revealing Higher order protein structure using mass spectrometry
10.1007/s13361-016-1385-1 · 2016
The concept of allosteric modulation: an overview
10.1016/j.ddtec.2012.07.007 · 2013
Algorithm selection for protein–ligand docking: strategies and analysis on ACE
2023
Structure-based maximal affinity model predicts small-molecule druggability
10.1038/nbt1273 · 2007
Automatic discovery of metastable states for the construction of Markov models of macromolecular conformational dynamics
10.1063/1.2714538 · 2007
Ion mobility mass spectrometry (IM-MS) for structural biology: insights gained by measuring mass, charge, and collision cross section
10.1021/acs.chemrev.2c00600 · 2023
Allosteric binding sites on cell-surface receptors: novel targets for drug discovery
10.1038/nrd746 · 2002
Disease progression modeling: key concepts and recent developments
10.1007/s40495-016-0066-x · 2016
Biophysical techniques in structural biology
10.1146/annurev-biochem-013118-111947 · 2019
Biomolecular simulation: a computational microscope for molecular biology
10.1146/annurev-biophys-042910-155245 · 2012
Cryogenic electron microscopy and single-particle analysis
10.1146/annurev-biochem-060614-034226 · 2015
Epigenetics in pancreatic ductal adenocarcinoma: impact on biology and utilization in diagnostics and treatment
10.3390/cancers14235926 · 2022
NMR as a “gold standard” method in drug design and discovery
10.3390/molecules25204597 · 2020
Fragment-based drug discovery: advancing fragments in the absence of crystal structures
10.1016/j.chembiol.2018.10.001 · 2019
Structure of sickled erythrocytes and of sickle-cell hemoglobin fibers
10.1073/pnas.70.3.718 · 1973
Allosteric antibodies: a novel paradigm in drug discovery
10.1016/j.tips.2024.10.007 · 2025
Progress in spatial resolution of structural analysis by cryo-EM
10.1093/jmicro/dfac053 · 2023
X-ray crystallography over the past decade for novel drug discovery -where are we heading next?
10.1517/17460441.2015.1061991 · doi-reference
Current limitations of solid-state NMR in carbohydrate and cell wall research
10.1016/j.jmr.2022.107263 · doi-reference
Artificial intelligence in drug development
10.1038/s41591-024-03434-4 · doi-reference
Recent progress and future challenges in structure-based protein-protein interaction prediction
10.1016/j.ymthe.2025.04.003 · doi-reference
Bringing structure to cell biology with cryo-electron tomography
10.1146/annurev-biophys-111622-091327 · doi-reference
Functions of intrinsically disordered regions
10.3390/biology14070810 · doi-reference
Understanding the invisible hands of sample preparation for cryo-EM
10.1038/s41592-021-01130-6 · doi-reference
Map/microtubule affinity regulating kinase 4 inhibitory potential of irisin: a new therapeutic strategy to combat cancer and alzheimer’s disease
10.3390/ijms222010986 · doi-reference
A fully differentiable ligand pose optimization framework guided by deep learning and a traditional scoring function
10.1093/bib/bbac520 · doi-reference
Identification of a universal antigen epitope of influenza A virus using peptide microarray
10.1186/s12917-020-02725-5 · doi-reference
10.1145/2623330.2623754
10.1145/2623330.2623754 · doi-reference
Prediction of protein–ligand binding affinity via deep learning models
10.1093/bib/bbae081 · doi-reference
A review of disease progression models of Parkinson's disease and applications in clinical trials
10.1002/mds.26644 · doi-reference
CADD, AI and ML in drug discovery: a comprehensive review
10.1016/j.ejps.2022.106324 · doi-reference
The mechanism of action of aspirin
10.1016/s0049-3848(03)00379-7 · doi-reference
Advances and opportunities in ultrafast X-ray crystallography and ultrafast structural optical crystallography of nuclear and electronic protein dynamics
10.1063/1.5110685 · doi-reference
Integrative, dynamic structural biology at atomic resolution - It's about time
10.1038/nmeth.3324 · doi-reference
The roles of intrinsically disordered proteins in neurodegeneration
10.1016/j.bbagen.2025.130772 · doi-reference
van der Wel, New applications of solid-state NMR in structural biology
10.1042/etls20170088 · doi-reference
Solid-state NMR studies of amyloid fibril structure
10.1146/annurev-physchem-032210-103539 · doi-reference
Highly accurate protein structure prediction for the human proteome
10.1038/s41586-021-03828-1 · doi-reference
Photon beam transport and scientific instruments at the European XFEL
10.3390/app7060592 · doi-reference
High-resolution native mass spectrometry
10.1021/acs.chemrev.1c00212 · doi-reference
Structural biology and drug discovery of difficult targets: the limits of ligandability
10.1016/j.chembiol.2011.12.013 · doi-reference
Graphene-based microfluidics for serial crystallography
10.1039/c6lc00451b · doi-reference
Binding affinity determination in drug design: insights from lock and key, induced fit, conformational selection, and inhibitor trapping models
10.3390/ijms25137124 · doi-reference
Statistical models for longitudinal biomarkers of disease onset
10.1002/(sici)1097-0258(20000229)19:4<617::aid-sim360>3.0.co;2-r · doi-reference
Multilayer optics for synchrotron applications
10.1002/admt.202302187 · doi-reference
Bioinformatics models in drug delivery: predicting biomaterial-biological interactions for targeted therapies
10.1016/j.nxnano.2025.100335 · doi-reference
Targeting tau in Alzheimer’s and beyond: insights into pathology and therapeutic strategies
10.1016/j.arr.2024.102639 · doi-reference
Chemical space overlap with critical protein–protein interface residues in commercial and specialized small-molecule libraries
10.1002/cmdc.201800537 · doi-reference
Multiscale methods for macromolecular simulations
10.1016/j.sbi.2008.07.003 · doi-reference
Mechanistic insight into binding of huperzine a with human serum albumin: computational and spectroscopic approaches
10.3390/molecules27030797 · doi-reference
Computational insight into the binding of bryostatin 1 with ferritin: implication of natural compounds in Alzheimer’s disease therapeutics
10.1080/07391102.2022.2092552 · doi-reference
Biological function investigated by time-resolved structure determination
10.1063/4.0000177 · doi-reference
Disease progression model in subjects with mild cognitive impairment from the Alzheimer's disease neuroimaging initiative: CSF biomarkers predict population subtypes
10.1111/j.1365-2125.2012.04308.x · doi-reference
Computational approaches streamlining drug discovery
10.1038/s41586-023-05905-z · doi-reference
Advancing cryo-EM and cryo-ET through innovation in sample carriers: a perspective
10.1021/acs.analchem.5c01534 · doi-reference
FUS and TDP-43 phases in health and disease
10.1016/j.tibs.2020.12.005 · doi-reference
A guide to time-resolved structural analysis of light-activated proteins
10.1111/febs.15880 · doi-reference